FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783806692> ?p ?o ?g. }

• W2783806692 endingPage "194" @default.
• W2783806692 startingPage "179" @default.
• W2783806692 abstract "To evaluate the pharmacodynamics of compounds in clinical development for nonalcoholic steatohepatitis (NASH) in obese mouse models of biopsy-confirmed NASH.Male wild-type C57BL/6J mice (DIO-NASH) and Lep ob/ob (ob/ob-NASH) mice were fed a diet high in trans-fat (40%), fructose (20%) and cholesterol (2%) for 30 and 21 wk, respectively. Prior to treatment, all mice underwent liver biopsy for confirmation and stratification of liver steatosis and fibrosis, using the nonalcoholic fatty liver disease activity score (NAS) and fibrosis staging system. The mice were kept on the diet and received vehicle, liraglutide (0.2 mg/kg, SC, BID), obeticholic acid (OCA, 30 mg/kg PO, QD), or elafibranor (30 mg/kg PO, QD) for eight weeks. Within-subject comparisons were performed on changes in steatosis, inflammation, ballooning degeneration, and fibrosis scores. In addition, compound effects were evaluated by quantitative liver histology, including percent fractional area of liver fat, galectin-3, and collagen 1a1.Liraglutide and elafibranor, but not OCA, reduced body weight in both models. Liraglutide improved steatosis scores in DIO-NASH mice only. Elafibranor and OCA reduced histopathological scores of hepatic steatosis and inflammation in both models, but only elafibranor reduced fibrosis severity. Liraglutide and OCA reduced total liver fat, collagen 1a1, and galectin-3 content, driven by significant reductions in liver weight. The individual drug effects on NASH histological endpoints were supported by global gene expression (RNA sequencing) and liver lipid biochemistry.DIO-NASH and ob/ob-NASH mouse models show distinct treatment effects of liraglutide, OCA, and elafibranor, being in general agreement with corresponding findings in clinical trials for NASH. The present data therefore further supports the clinical translatability and utility of DIO-NASH and ob/ob-NASH mouse models of NASH for probing the therapeutic efficacy of compounds in preclinical drug development for NASH." @default.
• W2783806692 created "2018-01-26" @default.
• W2783806692 creator A5001683046 @default.
• W2783806692 creator A5025702929 @default.
• W2783806692 creator A5066580974 @default.
• W2783806692 creator A5067265775 @default.
• W2783806692 creator A5069251431 @default.
• W2783806692 creator A5070898605 @default.
• W2783806692 creator A5075602116 @default.
• W2783806692 creator A5084927745 @default.
• W2783806692 creator A5088582143 @default.
• W2783806692 date "2018-01-14" @default.
• W2783806692 modified "2023-10-14" @default.
• W2783806692 title "Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis" @default.
• W2783806692 cites W1179310770 @default.
• W2783806692 cites W1856151485 @default.
• W2783806692 cites W1882068954 @default.
• W2783806692 cites W1959592008 @default.
• W2783806692 cites W1968265981 @default.
• W2783806692 cites W1969668125 @default.
• W2783806692 cites W1970253621 @default.
• W2783806692 cites W1978143294 @default.
• W2783806692 cites W1985210677 @default.
• W2783806692 cites W1989806714 @default.
• W2783806692 cites W1989908272 @default.
• W2783806692 cites W1990248309 @default.
• W2783806692 cites W1996415443 @default.
• W2783806692 cites W1996885736 @default.
• W2783806692 cites W1999617321 @default.
• W2783806692 cites W2014718725 @default.
• W2783806692 cites W2015643123 @default.
• W2783806692 cites W2029730391 @default.
• W2783806692 cites W2033361774 @default.
• W2783806692 cites W2035618305 @default.
• W2783806692 cites W2037598347 @default.
• W2783806692 cites W2049515100 @default.
• W2783806692 cites W2051601459 @default.
• W2783806692 cites W2060228800 @default.
• W2783806692 cites W2066841620 @default.
• W2783806692 cites W2067740038 @default.
• W2783806692 cites W2080361134 @default.
• W2783806692 cites W2092700213 @default.
• W2783806692 cites W2093009918 @default.
• W2783806692 cites W2098988372 @default.
• W2783806692 cites W2106768039 @default.
• W2783806692 cites W2111160264 @default.
• W2783806692 cites W2113653640 @default.
• W2783806692 cites W2120910422 @default.
• W2783806692 cites W2141246254 @default.
• W2783806692 cites W2145185779 @default.
• W2783806692 cites W2150748501 @default.
• W2783806692 cites W2153553562 @default.
• W2783806692 cites W2164556013 @default.
• W2783806692 cites W2164961630 @default.
• W2783806692 cites W2167909421 @default.
• W2783806692 cites W2169456326 @default.
• W2783806692 cites W2179438025 @default.
• W2783806692 cites W2204688218 @default.
• W2783806692 cites W2215535790 @default.
• W2783806692 cites W2224883440 @default.
• W2783806692 cites W2253420963 @default.
• W2783806692 cites W2328023807 @default.
• W2783806692 cites W2330887677 @default.
• W2783806692 cites W2410645250 @default.
• W2783806692 cites W2413093647 @default.
• W2783806692 cites W2415876542 @default.
• W2783806692 cites W2464238397 @default.
• W2783806692 cites W2467826416 @default.
• W2783806692 cites W2469365710 @default.
• W2783806692 cites W2522715783 @default.
• W2783806692 cites W2548766187 @default.
• W2783806692 cites W2549595017 @default.
• W2783806692 cites W2560175003 @default.
• W2783806692 cites W2576488295 @default.
• W2783806692 cites W2589458078 @default.
• W2783806692 cites W2590703216 @default.
• W2783806692 cites W2610037213 @default.
• W2783806692 cites W2613401321 @default.
• W2783806692 cites W2618863496 @default.
• W2783806692 cites W2730267177 @default.
• W2783806692 cites W2753966872 @default.
• W2783806692 cites W2765451895 @default.
• W2783806692 cites W4245650535 @default.
• W2783806692 doi "https://doi.org/10.3748/wjg.v24.i2.179" @default.
• W2783806692 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5768937" @default.
• W2783806692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29375204" @default.
• W2783806692 hasPublicationYear "2018" @default.
• W2783806692 type Work @default.
• W2783806692 sameAs 2783806692 @default.
• W2783806692 citedByCount "91" @default.
• W2783806692 countsByYear W27838066922018 @default.
• W2783806692 countsByYear W27838066922019 @default.
• W2783806692 countsByYear W27838066922020 @default.
• W2783806692 countsByYear W27838066922021 @default.
• W2783806692 countsByYear W27838066922022 @default.
• W2783806692 countsByYear W27838066922023 @default.
• W2783806692 crossrefType "journal-article" @default.
• W2783806692 hasAuthorship W2783806692A5001683046 @default.

• next